Highly Customized Cell & Protein Services

“Due to the outstanding flexibility to address our particular project needs as well as the excellent quality of the provided services, trenzyme is one of our preferred service providers for many years.”

Dr. Steffen Schaffer
Evonik Creavis GmbH, Marl, Germany

“No need to take the pipet in hand while relying on trenzyme!”

Prof. Dr. Roger Clerc
F. Hoffmann – La Roche Ltd, Basel, Switzerland

“It was a pleasure to work with trenzyme. Our expectations were fully met. trenzyme’s team of professional scientific experts helped us to complete our objectives in time. We were also pleased with the quality of the documentation provided. In a nutshell, I can recommend trenzyme as a reliable service provider.”

Michael Samassa
Celonic AG, Basel, Switzerland

“We appreciated trenzyme’s very open communication throughout the project and the detailed documentation provided. We are really happy with the outcome and would absolutely come to trenzyme again in the future for any custom proteins. Thank you to the whole team for their skills and effort in a good result, it is very exciting for us to be able to work with this material!”

Prof. Dr. Shana J. Sturla
ETH-Zurich, Department of Health Sciences and Technology, Zurich, Switzerland

“We highly valued the fast and excellent communication and the high flexibility of the team! For any future project, we will preferably entrust in trenzyme’s protein production services.”

Dr. Thore Hettmann
Probiodrug AG, Halle/Saale, Germany

“We were astonished by trenzyme’s recently delivered custom ExoIN cell lines. Even “difficult-to-express” constructs show stable and robust expression. I highly recommend trenzyme’s cell line development service.”

PD Dr. Dieter Wicher
Max Planck Institute for Chemical Ecology, Jena, Germany

“We highly appreciate the collaboration with trenzyme on account of the following reasons: trenzyme provides high quality material and services. The ‘outstanding’ team gives excellent advices, is skilled and professional. Direct and uncomplicated communication was possible at all times.”

Dr. Roland Lange
Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland

“We have expanded and tested the clonal cell lines and we are extremely happy with their performance. Needless to mention, that it was possible because the process of generation of cell lines at Trenzyme was very efficient and robust. I would definitely be interested in getting the engineered cell lines from Trenzyme in the future, if the need arises.”

Dr. Harish Pai
Biocon Research Center, Bangalore, India